Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Helicobacter Pylori Infection: full-pipeline trial registry
4 of 5 indexed Helicobacter Pylori Infection trials are currently recruiting.
Corpus placement: #3,391 of 28,707 conditions by registered trial count.
5 US clinical trials · 4 currently recruiting · #3,391 of 28,707 conditions by registered trial count
Helicobacter Pylori Infection: 5 US clinical trials tracked, 4 recruiting.
Helicobacter Pylori Infection is the subject of 5 registered US clinical trials on ClinicalTrials.gov, 4 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Phathom Pharmaceuticals, running 1 of these trials.
Enrollment posture brief
Registry condition helicobacter-pylori-infection
OPEN 4 | RECR 80% | LATE 1 | EARLY 1 | RANK #3391 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Acute Leukemia of Ambiguous Lineage (80% recruiting · 10 trials)
Helicobacter Pylori Infection lists 4 open slots (80% of 5 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Helicobacter Pylori Infection on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Helicobacter Pylori Infection is recruiting above its size-band peers.
4 of 5 indexed trials (80%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Helicobacter Pylori Infection research.
Phathom Pharmaceuticals accounts for 1 of 5 trials (20%). 5 distinct sponsors appear on at least one study for this condition label.
-
Most Helicobacter Pylori Infection trials plan to enrol fewer than 100 people.
Median target enrolment is 77 among the 5 trials that report a genuine target (sentinel values excluded). 3 of those (60%) plan for fewer than 100 participants.
-
Helicobacter Pylori Infection splits between interventional and observational designs.
3 interventional and 2 observational studies make up this index (60% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
5 total, page 1 of 1
A Study of the Safety of Vonoprazan Exposure in Pregnant Women and Their Offspring
Phathom Pharmaceuticals
NCT06660342
The GAstric Precancerous Conditions Study
Stanford University
NCT04191551
PyloPlus Urea Breath Test System Post Therapy Efficacy Confirmation Study
ARJ Medical
NCT05681689
H. Pylori Eradication With Argon Plasma During Endoscopy
Christopher C. Thompson, MD, MSc
NCT06529159
The Effect of H. Pylori Infection on Iron Metabolism
Seattle Institute for Biomedical and Clinical Research
NCT00202488
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 1 |
| Phase 3 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Helicobacter Pylori Infection records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Helicobacter Pylori Infection trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Helicobacter Pylori Infection page
5 registered trials, 4 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 4 Helicobacter Pylori Infection trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Phathom Pharmaceuticals sponsors the most Helicobacter Pylori Infection trials on record, review their full trial history before evaluating a specific study. See Phathom Pharmaceuticals's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Helicobacter Pylori Infection condition card totals 5 registered trials; most-linked intervention H. pylori treatment; top US site state Washington. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.